v3.26.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities    
Net loss $ (20,582) $ (18,094)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation 2,557 2,328
Amortization of deferred financing costs 19 26
Provision (benefit) for deferred income taxes 2 (174)
Change in fair value of derivative instruments 2,488 259
Stock based compensation 305 226
Gain on disposal of property and equipment 0 (31)
Change in allowance for credit losses 16 (1)
Change in inventory reserve 269 (453)
Noncash interest expense 9 9
Changes in operating assets and liabilities:    
Accounts receivable (3,923) 13,969
Inventory (2,037) (4,943)
Income tax receivable 6 6
Other assets (1,681) (6)
Dividends payable 8 0
Accrued expenses and other current liabilities 775 3,617
Deferred revenue (344) (31)
Other noncurrent liabilities (54) 333
Net cash used in operating activities (19,996) (5,395)
Cash flows from investing activities    
Collateralization of derivative instruments (934) (110)
Proceeds from the sale of property and equipment 0 31
Capital expenditures (5,387) (4,003)
Net cash used in investing activities (6,321) (4,082)
Cash flows from financing activities    
Payment of dividends (2,632) (2,628)
Deferred financing costs 0 (365)
Net cash used in financing activities (2,632) (2,993)
Net change in cash and cash equivalents (28,949) (12,470)
Cash and cash equivalents at beginning of period 51,316 109,541
Cash and cash equivalents at end of period 22,367 97,071
Non-cash activities    
Change in noncash capital expenditures 254 (407)
Nonrelated Party [Member]    
Changes in operating assets and liabilities:    
Prepaid expenses 1,237 1,075
Accounts payable 931 (3,404)
Related Party [Member]    
Changes in operating assets and liabilities:    
Prepaid expenses 0 (12)
Accounts payable $ 3 $ (94)